P. Kent Hawryluk's Net Worth
$0
Who is P. Kent Hawryluk?
P. Kent Hawryluk does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Gemphire Therapeutics Inc..
SEC CIK
P. Kent Hawryluk's CIK is 0001673991
Past Insider Trading and Trends
2016 was P. Kent Hawryluk's most active year for acquiring shares with 1 total transactions. P. Kent Hawryluk's most active month to acquire stocks was the month of December. 2016 saw P. Kent Hawryluk paying a total of $0.00 for 60,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gemphire Therapeutics Inc. (NRBO) Snapshot price: $3.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +43.95% | 25K |
$9.47 | $236,750.00 | 81.89K |
Mar 10
| |||
Form 4
|
∞
| 56.89K |
$8.37 |
—
| 56.89K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MBX Biosciences, Inc. (MBX) No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +83.30% | 399.76K |
—
|
—
| 879.67K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||